248 related articles for article (PubMed ID: 12023281)
1. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
[TBL] [Abstract][Full Text] [Related]
2. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
3. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
4. Novel regulation of Ski protein stability and endosomal sorting by actin cytoskeleton dynamics in hepatocytes.
Vázquez-Victorio G; Caligaris C; Del Valle-Espinosa E; Sosa-Garrocho M; González-Arenas NR; Reyes-Cruz G; Briones-Orta MA; Macías-Silva M
J Biol Chem; 2015 Feb; 290(7):4487-99. PubMed ID: 25561741
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
[TBL] [Abstract][Full Text] [Related]
7. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
8. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
9. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
Stroschein SL; Bonni S; Wrana JL; Luo K
Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
14. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
15. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
16. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
17. c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.
Pessah M; Marais J; Prunier C; Ferrand N; Lallemand F; Mauviel A; Atfi A
J Biol Chem; 2002 Aug; 277(32):29094-100. PubMed ID: 12034730
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
[TBL] [Abstract][Full Text] [Related]
19. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
20. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]